Author

Matthew C. Valdez

Observed name: Matthew Valdez

Institution: The University of Texas at San Antonio

Observed institutions: United States Department of Energy, Oak Ridge Institute for Science and Education, The University of Texas at San Antonio

ORCID: 0000-0002-5612-0007

Observed ORCID: 0000-0002-5612-0007

OpenAlex ID: A5089005385

Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015)

2016 · Stanton F. McHardy, Hua-Yu Leo Wang, et al. · Expert Opinion on Therapeutic Patents · 162

Synthesis and SAR of novel capsazepine analogs with significant anti-cancer effects in multiple cancer types

2018 · Jorge De La Chapa, Matthew Valdez, et al. · Bioorganic & Medicinal Chemistry · 22

The novel capsazepine analog, CIDD ‐99, significantly inhibits oral squamous cell carcinoma in vivo through a TRPV 1‐independent induction of ER stress, mitochondrial dysfunction, and apoptosis

2019 · Jorge J. De La Chapa, Prajjal K. Singha, et al. · Journal of Oral Pathology and Medicine · 11

Acute in vitro effects on embryonic rat dorsal root ganglion (DRG) cultures by in silico predicted neurotoxic chemicals: Evaluations on cytotoxicity, neurite length, and neurophysiology

2020 · Andrew F.M. Johnstone, Cina M. Mack, et al. · Toxicology in Vitro · 5

Inhibition of Ca2+ entry by capsazepine analog CIDD-99 prevents oral squamous carcinoma cell proliferation

2022 · Yuyang Sun, Emily K. Zboril, et al. · Frontiers in Physiology · 4

2022 · Manoj Aggarwal, James Akingbasote, et al. · Elsevier eBooks

Corrigendum to “Synthesis and SAR of novel capsazepine analogs with significant anti-cancer effects in multiple cancer types” [Bioorg. Med. Chem. 27 (1) (2019) 208–215]

2019 · Jorge De La Chapa, Matthew Valdez, et al. · Bioorganic & Medicinal Chemistry

Works count: 7

Citation count: 204

H-index: 4

I10-index: 3